Compounds > flubendazole
Page last updated: 2024-08-23

flubendazole and paclitaxel

flubendazole has been researched along with paclitaxel in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Cheong, JE; Chung, I; Jernigan, FE; Sun, L; Wang, Y; Xu, Y; Zaffagni, M; Zetter, BR1
Čáňová, K; Hanušová, V; Knoppová, K; Králová, V; Skálová, L; Staňková, P1
Bezzon, VDN; Bou-Chacra, NA; de Araujo, GLB; de Oliveira Faria, R; de Souza, GB; Lameu, C; Miyagi, MYS; Ozeki, T; Tagami, T; Yukuyama, MN1
Fu, L; Li, Z; Liao, M; Mou, Y; Wu, L; Ye, J; Zhen, Y; Zhou, Y1

Other Studies

4 other study(ies) available for flubendazole and paclitaxel

ArticleYear
Synthesis and anticancer activity of novel water soluble benzimidazole carbamates.
    European journal of medicinal chemistry, 2018, Jan-20, Volume: 144

    Topics: Animals; Antineoplastic Agents; Benzimidazoles; Carbamates; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Humans; Male; Mice; Molecular Docking Simulation; Molecular Structure; Neoplasms, Experimental; Solubility; Structure-Activity Relationship; Tumor Cells, Cultured; Water

2018
Antiproliferative effect of benzimidazole anthelmintics albendazole, ricobendazole, and flubendazole in intestinal cancer cell lines.
    Anti-cancer drugs, 2013, Volume: 24, Issue:9

    Topics: Adenocarcinoma; Albendazole; Anthelmintics; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Drug Synergism; G2 Phase; Humans; Inhibitory Concentration 50; Intestinal Neoplasms; Mebendazole; Microtubules; Paclitaxel; Protein Stability; Tubulin Modulators

2013
Optimizing adjuvant inhaled chemotherapy: Synergistic enhancement in paclitaxel cytotoxicity by flubendazole nanocrystals in a cycle model approach.
    International journal of pharmaceutics, 2023, Sep-25, Volume: 644

    Topics: Adjuvants, Immunologic; Adjuvants, Pharmaceutic; Nanoparticles; Paclitaxel; Powders

2023
Flubendazole Enhances the Inhibitory Effect of Paclitaxel via HIF1α/PI3K/AKT Signaling Pathways in Breast Cancer.
    International journal of molecular sciences, 2023, Oct-12, Volume: 24, Issue:20

    Topics: Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Humans; Paclitaxel; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction

2023